COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)
社区不信任和机构可信度措施 (COMMIT)
基本信息
- 批准号:10447250
- 负责人:
- 金额:$ 60.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAsthmaBaltimoreBaptist ChurchBehaviorBehavioralCOVID-19COVID-19 disparityCOVID-19 impactCOVID-19 morbidityCOVID-19 mortalityCOVID-19 pandemicCOVID-19 preventionCOVID-19 testingCenters for Disease Control and Prevention (U.S.)Clinical ResearchCollaborationsCommunitiesContractsData ReportingDiabetes MellitusDisastersDiscriminationEconomicsEmotionalEthicsFosteringFoundationsFundingFutureGoalsGrantHealthHealth Care ResearchHealth Disparities ResearchHealthcare SystemsHypertensionInfrastructureInstitutesInstitutionLeadLebanonLightMarylandMeasuresMedicalMethodsModelingMorbidity - disease rateNational Center for Advancing Translational SciencesNational Institute on Minority Health and Health DisparitiesObesityOutcomePatientsPharmacy SchoolsPharmacy facilityPlant RootsPopulationPopulation GroupPredispositionPublic HealthRADx Underserved PopulationsRecommendationResearchResearch PersonnelResource SharingRiskRunningSARS-CoV-2 infectionSeminalTestingTimeTraining ProgramsTranslational ResearchTreatment EffectivenessTrustUnderrepresented PopulationsUnderserved PopulationUnited StatesUnited States National Institutes of HealthUniversitiesVirginiaVulnerable PopulationsWorkWorkforce Developmentbasebehavior changecommunity engaged researchcommunity organizationsdisparity reductioneffectiveness evaluationethnic minority populationfightingfinancial relationshiphealth care deliveryhealth disparityhealth equityimprovedinfection rateinsightinter-institutionallensmedical vulnerabilitymembermortalitypandemic diseasepatient orientedpopulation healthpreferencepublic health emergencyracial biasracial minorityracismshared decision makingsocialsocial health determinantssocial vulnerabilitytreatment programtrustworthinessuptake
项目摘要
PROJECT SUMMARY/ABSTRACT
In the United States underserved and socially vulnerable populations have endured higher rates
and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden
has shown the light on the root causes of COVID-19 disparities such as longstanding systemic
racial bias in health care delivery, discrimination, and poor social determinants of health that
lead to health disparities for medical conditions such as asthma, diabetes, hypertension, and
obesity, all of which increase risk and susceptibility to COVID-19 and its sequalae. To address
these root causes, academic and other research institutions and health care systems must shift
their lens from one that focuses solely on changing behaviors among underserved and
vulnerable populations. Behaviors among health care and research institutions must change to
breakdown the structural barriers to trust, testing, treatment, and prevention of COVID-19. Prior
to asking patients and community members to trust in research and researchers, the focus
should be on radical institutional transformation to advance trustworthiness.
Trying to address social, ethical, and behavioral issues (SEBI) influencing access acceptability
and uptake of COVID-19 testing during a pandemic is extremely challenging, yet achievable
when there are existing community-academic partnerships. The distinction between trust and
trustworthiness suggests that trustworthiness is an antecedent to trust. Our proposed study will
employ a continuous engagement approach to advance institutional trustworthiness and
improve the strength of an existing community-engaged research (CEnR) partnership as well as
develop recommendations for the formation of similar inter-institutional partnerships with
community organizations in underserved populations.
In collaboration with community and community-based pharmacy partners, our Aims are:
Aim 1: Codesign a sustainable model for trustworthy CEnR partnerships to address SEBI of
COVID-19 testing
Aim 2: Assess best practices of trustworthy CEnR partnerships to address COVID-19 testing
SEBI factors
Aim 3: Codevelop an ethically-congruent memorandum of commitment (MOC) template for
CEnR partnerships for COVID-19 testing to advance trust through trustworthiness,
transparency, and respect
项目摘要/摘要
在美国,服务不足和社会脆弱的人口持续了更高的利率
Covid-19感染,发病率和死亡率的差异。这不成比例的负担
已经显示了共vid-19差距的根本原因,例如长期的全身性
卫生保健提供,歧视和健康决定因素的种族偏见,
导致哮喘,糖尿病,高血压和诸如医疗状况的健康差异
肥胖,所有这些都会增加对Covid-19及其序列的风险和敏感性。解决
这些根本原因,学术和其他研究机构以及医疗保健系统必须改变
他们的镜头来自仅关注服务不足和不断变化的行为的镜头
脆弱的人群。医疗保健和研究机构之间的行为必须改变为
破坏了Covid-19的信任,测试,治疗和预防的结构障碍。事先的
要要求患者和社区成员信任研究和研究人员,重点
应该进行激进的机构转型以提高信任度。
试图解决社会,道德和行为问题(SEBI)影响获得可接受性
大流行期间的Covid-19测试的吸收非常具有挑战性,但可以实现
当有现有的社区学术伙伴关系时。信任和
值得信赖的信任表明,可信度是信任的先例。我们提出的研究将
采用持续的参与方法来提高机构的信任度和
提高现有社区参与研究(CENR)合作伙伴关系的优势以及
为建立类似的机构间合作伙伴关系而制定建议
服务不足的人口的社区组织。
与社区和基于社区的药房合作伙伴合作,我们的目标是:
目标1:编码可信赖的CENR合作伙伴关系的可持续模型,以解决的SEBI
Covid-19测试
目标2:评估值得信赖的CENR合作伙伴关系的最佳实践,以解决COVID-19测试
SEBI因素
AIM 3:代码开发一份道德与一致的承诺备忘录(MOC)模板
CENR合作伙伴关系用于COVID-19测试,以通过可信赖性提高信任,
透明度和尊重
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
C. DANIEL MULLINS其他文献
C. DANIEL MULLINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('C. DANIEL MULLINS', 18)}}的其他基金
Developing InnoVative Equity-focused Regulatory SciencE (DIVERSE)
发展以股权为中心的创新监管科学(多元化)
- 批准号:
10838240 - 财政年份:2023
- 资助金额:
$ 60.49万 - 项目类别:
COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)
社区不信任和机构可信度措施 (COMMIT)
- 批准号:
10545060 - 财政年份:2022
- 资助金额:
$ 60.49万 - 项目类别:
Agency for Health Research and Quality (AHRQ) R24 Conference Grant Program (R13)
卫生研究与质量局 (AHRQ) R24 会议资助计划 (R13)
- 批准号:
9768971 - 财政年份:2018
- 资助金额:
$ 60.49万 - 项目类别:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
患者:以患者为中心参与评估治疗效果
- 批准号:
8734404 - 财政年份:2013
- 资助金额:
$ 60.49万 - 项目类别:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
患者:以患者为中心参与评估治疗效果
- 批准号:
8494177 - 财政年份:2013
- 资助金额:
$ 60.49万 - 项目类别:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
患者:以患者为中心参与评估治疗效果
- 批准号:
8932009 - 财政年份:2013
- 资助金额:
$ 60.49万 - 项目类别:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
患者:以患者为中心参与评估治疗效果
- 批准号:
9145184 - 财政年份:2013
- 资助金额:
$ 60.49万 - 项目类别:
PATIENTS: PATient-centered Involvement in Evaluating effectivNess of Treatment
患者:以患者为中心参与评估治疗效果
- 批准号:
9357515 - 财政年份:2013
- 资助金额:
$ 60.49万 - 项目类别:
Do Bayesian Adaptive Trials Offer Advantages for CER?
贝叶斯自适应试验是否为 CER 提供优势?
- 批准号:
8036399 - 财政年份:2010
- 资助金额:
$ 60.49万 - 项目类别:
Response to Medicare Reimbursement Policy Change by Minority and All ESRD Patient
少数族裔和所有 ESRD 患者对医疗保险报销政策变更的回应
- 批准号:
7496311 - 财政年份:2008
- 资助金额:
$ 60.49万 - 项目类别:
相似国自然基金
LPGAT1介导的磷脂重塑影响Treg细胞分化及功能参与哮喘发病机制研究
- 批准号:82370032
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
咳喘停穴位贴敷通过PI3K/AKT/c-Rel调控ILC2s-ICOSL影响Th2免疫应答参与过敏性哮喘的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
哮喘易感转录因子Bach2调控Treg细胞影响气道高反应性的作用机制研究
- 批准号:82270027
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
哮喘患者痛觉异常对电针疗效影响的动态脑效应机制研究
- 批准号:82205267
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
固本防哮饮调控RTN4B介导鞘脂代谢稳态影响哮喘气道重塑的机制研究
- 批准号:82205186
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 60.49万 - 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
- 批准号:
10723233 - 财政年份:2023
- 资助金额:
$ 60.49万 - 项目类别:
Impact of benzene-induced MIA on fetal T cell development
苯诱导的 MIA 对胎儿 T 细胞发育的影响
- 批准号:
10605881 - 财政年份:2023
- 资助金额:
$ 60.49万 - 项目类别:
Expanding Access to Care for Marginalized Caregivers through Innovative Methods for Multicultural and Multilingual Adaptation of AI-Based Health Technologies
通过基于人工智能的医疗技术的多文化和多语言适应创新方法,扩大边缘化护理人员获得护理的机会
- 批准号:
10741177 - 财政年份:2023
- 资助金额:
$ 60.49万 - 项目类别:
Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma
SARS-CoV-2 感染对患有和不患有哮喘的儿童呼吸道病毒免疫反应的影响
- 批准号:
10568344 - 财政年份:2023
- 资助金额:
$ 60.49万 - 项目类别: